Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
BULLISH SIGNAL DETECTED
██.█% Sign up free to reveal

Penumbra Inc (PEN) AI Forecast

Our AI detected a significant signal for Penumbra Inc. Create a free account to see the exact price target.

Free account • 30-day free trial

$PEN Bullish Signal Full forecast available

Penumbra Inc (PEN) AI Stock Price Forecast & Investment Analysis

Penumbra Inc Stock Price Chart and Technical Analysis

Loading chart...

Penumbra Inc (PEN) - Comprehensive Stock Analysis & Investment Research

Deep dive into Penumbra Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 17, 2026, 9:25 a.m. (UTC)

Penumbra Inc Investment Summary

When evaluating whether Penumbra Inc (PEN) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Penumbra Inc (PEN) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. The company employs approximately 2,391 people. With a market capitalization of $13 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Penumbra Inc's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Penumbra Inc along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Penumbra Inc is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Penumbra Inc

Sign Up Free
Corporate Identity

Penumbra Inc (Stock Symbol: PEN) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Penumbra Inc's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Penumbra Inc...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Penumbra Inc...

Unlock Full Company Profile

Get complete details about Penumbra Inc

Sign Up Free
Revenue & Growth Analysis

Penumbra Inc generates annual revenues of $1 billion , indicating a well-established business with proven market demand.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Penumbra Inc...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Penumbra Inc...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Penumbra Inc...

Unlock Financial Analysis

Get complete financial metrics for Penumbra Inc

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Penumbra Inc's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Penumbra Inc strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Penumbra Inc competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-3 million , with year-over-year cash flow growth of -7.5%. Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Margin & Pricing Power Analysis

The company maintains a 62.8% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.

Operating margin of 0.1% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Asset Utilization Efficiency

Asset turnover ratio of 0.73x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Current ratio of 5.31 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Penumbra Inc (PEN) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Penumbra Inc stock analysis.

Deep dive into Penumbra Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Penumbra Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Penumbra Inc: With a P/E ratio of 74.22, the market highly values future growth prospects.

P/E Ratio 74.22x
P/B Ratio 9.24x
Market Cap $13.19B
EPS $3.81
Book Value/Share $36.39
Revenue/Share $35.78
FCF/Share $-1.55
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Penumbra Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Penumbra Inc: An ROE of -0.8% indicates room for improvement in shareholder value creation.

ROE -0.8%
ROA -0.6%
ROIC -0.7%
Gross Margin 62.8%
Operating Margin 0.1%
Net Margin 3.0%
EBT Margin -3.6%
Tax Rate 0.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Penumbra Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Penumbra Inc: A current ratio of 5.31 indicates strong liquidity.

Current Ratio 5.31x
Quick Ratio 2.95x
D/E Ratio 0.22x
Financial Leverage 1.36x
Working Capital $512M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Penumbra Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Penumbra Inc: Free cash flow of $-3M indicates cash challenges that need attention.

Operating Cash Flow $19M
Free Cash Flow -$3M
Capital Spending -$22M
OCF Growth YoY -7.5%
FCF Growth YoY -76.3%
FCF/Sales -0.4%
CapEx/Sales 2.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Penumbra Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Penumbra Inc: An asset turnover of 0.73x suggests room for improvement in asset utilization.

Asset Turnover 0.73x
Receivables Turnover 5.8x
Inventory Turnover 1.1x
Fixed Assets Turnover 3.9x
Days Sales Outstanding 63 days
Days Inventory 326 days
Payables Period 19 days
Cash Conversion Cycle 371 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Penumbra Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Penumbra Inc: With annual revenue of $1403M, Penumbra Inc operates at significant scale.

Income Statement
Total Revenue $1.40B
R&D Expense $20M
SG&A Expense $52M
Cost of Goods Sold $422M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 53%
Cash & Short-term Investments 18%
Total Liabilities 26%
Accounts Receivable 11%
Inventory 21%
Dividend & Shareholder Information
Shares Outstanding 39M
Growth Metrics (YoY)
EPS Growth 0.3%

Latest Penumbra Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Penumbra Inc (PEN) stock price and investment outlook.

📰 We are currently updating our news feed for Penumbra Inc. Check back soon for the latest market analysis and company updates.

Penumbra Inc Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Penumbra Inc against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Adagio Medical Holdings, Inc. ADGM ██% $23M x 2.6x
Aethlon Medical Inc AEMD ██% $3M -0.1x 0.4x
Acutus Medical, Inc. AFIB ██% $0.00M 0.0x -0.4x
Allurion Technologies, Inc. ALUR ██% $6M -0.4x -0.3x
Autonomix Medical, Inc. AMIX ██% $5M x 0.6x
Angiodynamics Inc ANGO ██% $441M -1.4x 2.5x
Anika Therapeutics, Inc. ANIK ██% $199M -4.3x 1.4x
Artivion, Inc. AORT ██% $1.70B 173.6x 3.8x
Apyx Medical Corp APYX ██% $153M -3.5x 10.6x
Accuray Inc ARAY ██% $49M -9.9x 0.9x
Alphatec Holdings, Inc. ATEC ██% $1.88B -7.4x 151.2x
Atricure, Inc. ATRC ██% $1.52B -39.6x 3.1x
Nuo Therapeutics, Inc. AURX ██% $64M x 72.1x
Avita Medical, Inc. AVHHL ██% $22M x x
Baxter International Inc BAX ██% $8.76B -94.9x 1.4x
Beta Bionics, Inc. BBNX ██% $482M x 1.7x
Becton Dickinson & Co BDX ██% $58.07B 33.1x 2.3x
Heartbeam, Inc. BEAT ██% $51M -5.7x 19.6x
Bluejay Diagnostics, Inc. BJDX ██% $2M -0.5x 0.3x
Boston Scientific Corp BSX ██% $103.32B 35.7x 4.3x
Biotricity Inc. BTCY ██% $7M -2.7x 3.0x
Bioventus Inc. BVS ██% $573M 25.2x 3.1x
Brainsway Ltd. BWAY ██% $535M x x
Carlsmed, Inc. CARL ██% $311M x 3.2x
Cerus Corp CERS ██% $346M -13.8x 5.4x
Clearpoint Neuro, Inc. CLPT ██% $314M -23.5x 19.8x
Co-Diagnostics, Inc. CODX ██% $5M -0.7x 0.1x
Cytosorbents Corp CTSO ██% $41M -1.8x 4.5x
Cvrx, Inc. CVRX ██% $207M -5.5x 5.3x
Delcath Systems, Inc. DCTH ██% $329M 121.8x 3.0x
Dih Holding Us, Inc. DHAI ██% $70K x -0.3x
Dariohealth Corp. DRIO ██% $57M 0.6x 0.8x
Alpha Tau Medical Ltd. DRTS ██% $638M x 8.3x
Dexcom Inc DXCM ██% $25.11B 30.0x 9.1x
Dynatronics Corp DYNT ██% $540K -0.2x 0.2x
Ebr Systems, Inc. EBRCZ ██% $225M x 5.8x
Encision Inc ECIA ██% $3M x 1.4x
Embecta Corp. EMBC ██% $522M 3.7x -0.8x
Electromedical Technologies, Inc EMED ██% $750K x x
Femasys Inc FEMY ██% $34M -1.4x 7.4x
Family Office Of America, Inc. FOFA ██% $76M x 94.2x
Glucotrack, Inc. GCTK ██% $1M 0.9x 0.5x
Global Innovative Platforms Inc. GIPL ██% $320K x 2.0x
Glaukos Corp GKOS ██% $5.69B -46.3x 8.7x
Globus Medical Inc GMED ██% $11.60B 21.6x 2.5x
Fractyl Health, Inc. GUTS ██% $71M x 11.2x
Haemonetics Corp HAE ██% $2.80B 15.9x 3.1x
Harvard Apparatus Regenerative Technology, Inc. HRGN ██% $30M x 19.0x
Integra Lifesciences Holdings Corp IART ██% $691M 200.2x 0.7x
Icecure Medical Ltd. ICCM ██% $50M x 17.4x
Seastar Medical Holding Corp ICU ██% $88M -1.1x 7.7x
Icu Medical Inc/De ICUI ██% $3.13B 4282.0x 1.5x
Interpace Biosciences, Inc. IDXG ██% $48M 9.9x 7.0x
Inspira Technologies Oxy B.H.N. Ltd IINN ██% $26M x 6.0x
Inspira Technologies Oxy B.H.N. Ltd IINNW ██% $7M x 1.5x
Intelligent Bio Solutions Inc. INBS ██% $6M -0.3x 0.6x
Infusystem Holdings, Inc INFU ██% $169M 30.5x 3.0x
Inspire Medical Systems, Inc. INSP ██% $1.70B 11.7x 2.2x
Iradimed Corp IRMD ██% $1.27B 56.7x 13.5x
Irhythm Holdings, Inc. IRTC ██% $3.65B -20.2x 23.9x
Invo Fertility, Inc. IVF ██% $6M x 1.0x
Orthopediatrics Corp KIDS ██% $434M -20.7x 1.3x
Kestra Medical Technologies, Ltd. KMTS ██% $1.30B x x
Koru Medical Systems, Inc. KRMD ██% $211M -19.8x 12.8x
Lemaitre Vascular Inc LMAT ██% $2.46B 42.6x 6.3x
Lensar, Inc. LNSR ██% $140M -6.7x 28.7x
Lucid Diagnostics Inc. LUCD ██% $188M -0.6x 7.3x
Pulmonx Corp LUNG ██% $70M -4.3x 1.3x
Lyra Therapeutics, Inc. LYRA ██% $2M -0.1x 1.3x
Microbot Medical Inc. MBOT ██% $183M -1.3x 2.3x
Mountain Crest Acquisition Corp. V MCAG ██% $34M x 1509.8x
Mountain Crest Acquisition Corp. V MCAGU ██% $31M x -9.9x
Spectral Ai, Inc. MDAI ██% $41M -1.3x 27.8x
Medinotec Inc. MDNC ██% $59M 25.1x 10.7x
Mimedx Group, Inc. MDXG ██% $649M 13.4x 2.5x
Monogram Technologies Inc. MGRM ██% $217M -10.7x 25.1x
Meihua International Medical Technologies Co., Ltd. MHUA ██% $151M x 0.9x
3m Co MMM ██% $80.05B 24.6x 17.0x
Merit Medical Systems Inc MMSI ██% $4.16B 32.4x 2.6x
Modular Medical, Inc. MODD ██% $31M -2.1x 5.3x
Nephros Inc NEPH ██% $37M 31.2x 4.5x
Neuroone Medical Technologies Corp NMTC ██% $38M -1.7x 5.9x
Neuropace Inc NPCE ██% $473M -10.4x 24.9x
Inspiremd, Inc. NSPR ██% $69M -4.3x 1.1x
Nu-Med Plus, Inc. NUMD ██% $1M x 5.3x
Novocure Ltd NVCR ██% $1.36B -20.8x 4.0x
Envveno Medical Corp NVNO ██% $7M x 0.2x
Nexgel, Inc. NXGL ██% $7M -6.8x 1.3x
Nyxoah Sa NYXH ██% $140M x x
Orchestra Biomed Holdings, Inc. OBIO ██% $250M -3.4x 2.5x
Odyssey Health, Inc. ODYY ██% $5M x 0.7x
Orthofix Medical Inc. OFIX ██% $466M -5.8x 1.0x
Osr Holdings, Inc. OSRH ██% $11M x 0.1x
Orasure Technologies Inc OSUR ██% $216M 17.1x 0.6x
Pavmed Inc. PAVM ██% $9M 3.0x 0.3x
Pro Dex Inc PDEX ██% $156M 13.7x 3.7x
Penumbra Inc PEN ██% $13.19B 74.2x 9.2x
Petvivo Holdings, Inc. PETV ██% $28M -1.4x 8.2x
Polyrizon Ltd. PLRZ ██% $15M x 0.8x
Pulse Biosciences, Inc. PLSE ██% $1.46B -2.6x 18.1x
Picard Medical, Inc. PMI ██% $96M x 12.0x
Insulet Corp PODD ██% $15.47B 62.6x 10.2x
Procept Biorobotics Corp PRCT ██% $1.49B -45.4x 4.1x
Premier Air Charter Holdings Inc. PREM ██% $2M x 2.8x
Profound Medical Corp. PROF ██% $200M x 3.0x
Plus Therapeutics, Inc. PSTV ██% $45M -0.3x 11.2x
Polypid Ltd. PYPD ██% $76M x 7.0x
Avita Medical, Inc. RCEL ██% $135M -5.0x 29.9x
Vivos Inc RDGL ██% $39M x 17.6x
Resmed Inc RMD ██% $33.62B 22.6x 5.3x
Resmed Inc RSMDF ██% $3.82B 2.7x 0.6x
Retinalgenix Technologies Inc. RTGN ██% $60M x x
Retractable Technologies Inc RVP ██% $21M -0.9x 0.3x
Sight Sciences, Inc. SGHT ██% $196M -3.7x 3.1x
Si-Bone, Inc. SIBN ██% $570M -14.3x 3.2x
Sigyn Therapeutics, Inc. SIGY ██% $130K x 0.4x
Sintx Technologies, Inc. SINT ██% $10M x 2.6x
Beauty Health Co SKIN ██% $162M -1.8x 2.7x
Sonoma Pharmaceuticals, Inc. SNOA ██% $4M -5.6x 1.2x
Sanuwave Health, Inc. SNWV ██% $185M x 176.1x
Solventum Corp SOLV ██% $11.58B 7.4x 2.3x
Sensus Healthcare, Inc. SRTS ██% $64M 31.6x 1.3x
Ss Innovations International, Inc. SSII ██% $895M x 23.4x
Strata Skin Sciences, Inc. SSKN ██% $2M -8.0x 1.2x
Neuronetics, Inc. STIM ██% $89M -1.0x 3.2x
Stimcell Energetics Inc. STME ██% $6M x 983.5x
Sharps Technology Inc. STSS ██% $52M -2.5x 0.1x
Stevanato Group S.P.A. STVN ██% $4.09B x x
Stryker Corp SYK ██% $128.71B 39.7x 11.0x
Tactile Systems Technology Inc TCMD ██% $604M 31.7x 2.8x
Tela Bio, Inc. TELA ██% $30M -1.8x 19.6x
Teleflex Inc TFX ██% $4.79B 31.0x 1.5x
Trisalus Life Sciences, Inc. TLSI ██% $244M -3.6x 28.8x
Trisalus Life Sciences, Inc. TLSIW ██% $62M x -1.9x
Treace Medical Concepts, Inc. TMCI ██% $92M -7.5x 1.1x
Tandem Diabetes Care Inc TNDM ██% $1.47B -17.1x 9.5x
Tenon Medical, Inc. TNON ██% $9M -0.3x 1.9x
T2 Biosystems, Inc. TTOO ██% $210K 0.0x -0.3x
Ufp Technologies Inc UFPT ██% $1.57B 23.0x 3.7x
Qhslab, Inc. USAQ ██% $9M x 116.5x
Utah Medical Products Inc UTMD ██% $203M 17.5x 1.7x
Venus Concept Inc. VERO ██% $720K 0.0x 0.3x
Catheter Precision, Inc. VTAK ██% $2M x 0.4x
Vivos Therapeutics, Inc. VVOS ██% $14M x 5.6x
Vycor Medical Inc VYCO ██% $3M x 40.2x
West Pharmaceutical Services Inc WST ██% $16.95B 34.3x 5.3x
Beyond Air, Inc. XAIR ██% $9M -0.3x 1.1x
Xtant Medical Holdings, Inc. XTNT ██% $87M 49.7x 1.7x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Penumbra Inc Stock Forecast

How accurate are Penumbra Inc stock predictions?

Our AI model shows a -15% Spearman correlation coefficient for PEN predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Penumbra Inc stock price forecasts?

Our analysis considers Penumbra Inc's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Penumbra Inc a good investment in 2025?

Based on our AI analysis, Penumbra Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Penumbra Inc forecasts updated?

Penumbra Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...